Page last updated: 2024-11-07

prednisone and Nerve Root Avulsion

prednisone has been researched along with Nerve Root Avulsion in 12 studies

Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.

Research Excerpts

ExcerptRelevanceReference
"The prednisone-treated group showed an adjusted mean 6."2.80Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial. ( Ackerson, L; Avins, AL; Carragee, E; Carver, R; Firtch, W; Goldberg, H; Hamilton, L; Maratukulam, A; Pressman, A; Smith, W; Tyburski, M; Won, LA, 2015)

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19902 (16.67)18.7374
1990's3 (25.00)18.2507
2000's3 (25.00)29.6817
2010's3 (25.00)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Pérez-Jacoiste Asín, MA1
Calleja-Castaño, P1
Hilario, A1
Goldberg, H1
Firtch, W1
Tyburski, M1
Pressman, A1
Ackerson, L1
Hamilton, L1
Smith, W1
Carver, R1
Maratukulam, A1
Won, LA1
Carragee, E1
Avins, AL1
Cohen, SP1
Fumeaux, T1
GARGOUR, G1
MACGAFFEY, K1
LOCKE, S1
STEIN, MD1
Ferrari, TC2
Moreira, PR1
Cunha, AS1
Rabar, D1
Issartel, B1
Petiot, P1
Boibieux, A1
Chidiac, C1
Peyramond, D1
Araújo, KC1
Rosa e Silva, Cd1
Barbosa, CS1
Andrade Filho, Ade S1
Reis, MG1
de Souza, AL1
Martins, ER1
Santos, SR1
Ancilon, M1
Lima, JM1
de Queiroz, AC1
Guimarães, MD1
Moreno-Carvalho, OA1
Rêgo, MF1
Kozakiewicz, RT1
Hennessey, WJ1
Naidoo, DP1
Desai, D1
Kranidiotis, L1
Bammer, HG1

Clinical Trials (2)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Methylprednisolone Taper to Treat Delayed Post-Operative Recovery After Total Knee Arthroplasty: a Double-Blind Randomized Controlled Trial[NCT05113901]Phase 44 participants (Actual)Interventional2022-03-03Terminated (stopped due to Extremely low participation, decided to focus on similar study instead)
A Corticosteroid Taper for Acute Sciatica Treatment (The ACT FAST Study)[NCT00668434]Phase 2269 participants (Actual)Interventional2008-11-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Adverse Events or Outcomes Outside of Manipulations Under Anesthesia

Adverse outcomes including infection, avascular necrosis, and 90-day readmission rates (NCT05113901)
Timeframe: within 90 days after initial total knee arthroplasty

InterventionParticipants (Count of Participants)
Methylprednisolone Taper0
Placebo Taper0

Number of Participants With Complications Following Treatment

Manipulations under anesthesia (MUAs) following total knee arthroplasty surgery and treatment (NCT05113901)
Timeframe: within 90 days after initial total knee arthroplasty

InterventionParticipants (Count of Participants)
Methylprednisolone Taper0
Placebo Taper0

Patient Reported Outcome Measures: Overall Assessment of Knee 6 Weeks After Treatment

Single Assessment Numeric Evaluation (SANE), a single-question patient rating of 0-100, scoring their function to the area being treated. Zero represents a poor functional knee and 100 is the best functioning. (NCT05113901)
Timeframe: 6 weeks after treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper89.5

Patient Reported Outcome Measures: Overall Assessment of Knee 6 Weeks After Treatment

UCLA activity score, on a scale of 1 to 10 where 10 is the most active patient with examples of activities (NCT05113901)
Timeframe: 6 weeks after treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper5.25

Patient Reported Outcome Measures: Overall Assessment of Knee 6 Weeks After Treatment

VR-12: Assesses physical functioning, physical/ mental limitations. Scored as summary of mental and physical, measure in standard deviations. The scale range is 0 to 100, where a score of 100 represents the best physical and mental health and zero is the worst outcome. (NCT05113901)
Timeframe: 6 weeks after treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper50.28

Patient Reported Outcome Measures: Overall Assessment of Knee 6 Wks After Treatment

Forgotten Joint Score (FJS) is a survey scored ranging from 0 to 100, where a high score indicates a high degree of a forgetting they have an artificial joint, which is an ideal outcome. (NCT05113901)
Timeframe: 6 weeks after treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper57.82

Patient Reported Outcome Measures: Overall Assessment of Knee After Surgery and Treatment

Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR), a survey given to patients standard of care containing 7 questions. The score ranges from 0 to 100 where zero represents total disability and 100 represents a perfect knee health. (NCT05113901)
Timeframe: 6 weeks after treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper72.12

Patient Reported Outcome Measures: Overall Assessment of Knee After Surgery and Treatment

Knee Injury and Osteoarthritis Outcome Score for Joint Replacement (KOOS JR), a survey given to patients standard of care containing 7 questions. The score ranges from 0 to 100 where zero represents total disability and 100 represents a perfect knee health. (NCT05113901)
Timeframe: pre treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper50.04

Patient Reported Outcome Measures: Overall Assessment of Knee Before Treatment

Single Assessment Numeric Evaluation (SANE), a single-question patient rating of 0-100, scoring their function to the area being treated. Zero represents a poor functional knee and 100 is the best functioning. (NCT05113901)
Timeframe: pre treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper29.5

Patient Reported Outcome Measures: Overall Assessment of Knee Before Treatment

Veterans Rand 12-Item Health Survey (VR-12), a survey of 12 questions to measure health relating to patient's quality of life. Scored as summary of mental and physical, measure in standard deviations. The scale range is 0 to 100, where a score of 100 represents the best physical and mental health and zero is the worst outcome. (NCT05113901)
Timeframe: pre treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper38.73

Patient Reported Outcome Measures: Overall Assessment of Knee Prior to Treatment

Forgotten Joint Score (FJS) is a survey scored ranging from 0 to 100, where a high score indicates a high degree of a forgetting they have an artificial joint, which is an ideal outcome. (NCT05113901)
Timeframe: pre treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper91.67

Patient Reported Outcome Measures: Overall Assessment of Knee Prior to Treatment

UCLA activity score, on a scale of 1 to 10 where 10 is the most active patient with examples of activities (NCT05113901)
Timeframe: pre treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper4.25

Patient Reported Outcome Measures: Post Treatment Pain Scores

"Knee society score (KSS); done standard of care on a scale of 0-100, where 100 means a more functional knee.~**Please note, the study was terminated early, only 4 subjects were enrolled and none were randomized to the placebo group. At 3 weeks post treatment, only 3 of the 4 subjects enrolled were still part of the study." (NCT05113901)
Timeframe: 3 weeks post treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper68.33

Patient Reported Outcome Measures: Post Treatment Pain Scores

"Knee society score (KSS); done standard of care on a scale of 0-100, where 100 means a more functional knee.~**Please note, the study was terminated early, only 4 subjects were enrolled and none were randomized to the placebo group. This is a standard of care survey available on all subjects." (NCT05113901)
Timeframe: 6 weeks post treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper78.75

Patient Reported Outcome Measures: Post Treatment Pain Scores (6 Weeks)

"Using daily defense and veterans pain rating scale (DVPRS) on a scale of 1 to 10, 10 being the worst.~Please note, only one patient made it to the 6 week post treatment mark of the 4 enrolled. The study was terminated and none of the patients were randomized to the placebo group. All other patients followed up but were not interested in continuing. No range could be provided given only one subject answered and completed this visit" (NCT05113901)
Timeframe: 6 weeks post treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper1.93

Patient Reported Outcome Measures: Pre Treatment Pain Scores Using Knee Society Scores

"Knee society score (KSS); done standard of care on a scale of 0-100, where 100 means a more functional knee~**Please note, the study was terminated early, only 4 subjects were enrolled and none were randomized to the placebo group." (NCT05113901)
Timeframe: pre treatment

Interventionscore on a scale (Mean)
Methylprednisolone Taper66.25

Patient Reported Outcome Measures:(Immediate) Post Treatment Pain Scores

"Using Daily Visual Analogue Scale (VAS) pain score, which measures intensity of pain on a scale of 0 (no pain) to 10 (worst pain possible).~**Please note, this study was terminated early, only enrolling 4 patients, none were randomized to the placebo group." (NCT05113901)
Timeframe: Days 1 through 6 following treatment

Interventionscore on a scale (Mean)
Day 1Day 2Day 3Day 4Day 5Day 6
Methylprednisolone Taper2.3331.331.331.672.3

Range of Motion in Degrees at Pre and Post Treatment

"Range of motion (ROM) from pre-treatment to six weeks following treatment. Patients started treatment after total knee replacement surgery and presented to clinic with at least one inclusion criteria to be enrolled. Range of motion in degrees is taken at each visit by a clinician (standard of care), starting at zero degrees (straight leg) to about 135 degrees. The ROM was documented as part of consenting and enrollment into study. Subjects returned to the office at 6 weeks post treatment where ROM was performed in a clinic setting once again and documented. ROM is done using a goniometer by a clinician in each clinic.~This study was terminated early, therefore of the 4 enrolled, zero were randomized to the placebo group. Only 1 of the four subjects completed the 6 weeks, however, ROM was captured on all as standard of care." (NCT05113901)
Timeframe: Baseline, Week 6 Following Treatment

InterventionRange of Motion in Degrees (Mean)
Pre treatmentPost treatment
Methylprednisolone Taper82.5112

Oswestry Disability Index, v2

The Oswestry Disability Index, v2 is a back-pain-specific measure of disability and functional status. It is measured on a 0-to-100 scale, with higher numbers indicating greater disability. (NCT00668434)
Timeframe: Baseline, Week 3 follow-up

Interventionunits on a scale (Mean)
Prednisone-19.0
Placebo-13.3

Oswestry Disability Index, v2

The Oswestry Disability Index, v2 is a back-pain-specific measure of disability and functional status. It is measured on a 0-to-100 scale, with higher numbers indicating greater disability. (NCT00668434)
Timeframe: Baseline, Week 52 follow-up

Interventionunits on a scale (Mean)
Prednisone-37.8
Placebo-30.4

Pain Numerical Rating Scale

Ordinal scale of average level of pain as perceived by the participant over the prior 3 days; measured on a 0-to-10 scale, with higher numbers indicating greater pain. (NCT00668434)
Timeframe: Baseline, Week 3 follow-up

Interventionunits on a scale (Mean)
Prednisone-3.0
Placebo-2.8

Pain Numerical Rating Scale

Ordinal scale of average level of pain as perceived by the participant over the prior 3 days; measured on a 0-to-10 scale, with higher numbers indicating greater pain. (NCT00668434)
Timeframe: Baseline, Week 52 follow-up

Interventionunits on a scale (Mean)
Prednisone-5.2
Placebo-4.6

Trials

1 trial available for prednisone and Nerve Root Avulsion

ArticleYear
Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial.
    JAMA, 2015, May-19, Volume: 313, Issue:19

    Topics: Acute Disease; Administration, Oral; Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Gl

2015
Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial.
    JAMA, 2015, May-19, Volume: 313, Issue:19

    Topics: Acute Disease; Administration, Oral; Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Gl

2015
Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial.
    JAMA, 2015, May-19, Volume: 313, Issue:19

    Topics: Acute Disease; Administration, Oral; Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Gl

2015
Oral steroids for acute radiculopathy due to a herniated lumbar disk: a randomized clinical trial.
    JAMA, 2015, May-19, Volume: 313, Issue:19

    Topics: Acute Disease; Administration, Oral; Adult; Aged; Double-Blind Method; Female; Follow-Up Studies; Gl

2015

Other Studies

11 other studies available for prednisone and Nerve Root Avulsion

ArticleYear
Lumbosacral Radiculopathy as the Clinical Presentation of Neurocysticercosis.
    The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6

    Topics: Adult; Albendazole; Anthelmintics; Anti-Inflammatory Agents; Antibodies, Helminth; Female; Humans; I

2020
Oral steroids for improved function but not pain in acute radiculopathy due to disc herniation.
    Evidence-based medicine, 2015, Volume: 20, Issue:4

    Topics: Female; Glucocorticoids; Humans; Intervertebral Disc Displacement; Lumbar Vertebrae; Male; Prednison

2015
[What is the role of oral steroids in the treatment of acute sciatic?].
    Revue medicale suisse, 2015, Jun-10, Volume: 11, Issue:478

    Topics: Female; Glucocorticoids; Humans; Intervertebral Disc Displacement; Lumbar Vertebrae; Male; Prednison

2015
ANTERIOR RADICULOPATHY AND LUPUS ERYTHEMATOSUS CELLS: REPORT OF A CASE.
    British medical journal, 1964, Sep-26, Volume: 2, Issue:5412

    Topics: Cerebrospinal Fluid Proteins; Fluorescent Antibody Technique; Humans; Lupus Erythematosus, Systemic;

1964
Spinal cord schistosomiasis: a prospective study of 63 cases emphasizing clinical and therapeutic aspects.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2004, Volume: 11, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Inflammatory Agents; Antiplatyhelmintic Agents; Biopsy; Child; Child,

2004
[Tuberculoma and tuberculous meningeal-radiculitis with paradoxical progression during treatment].
    Presse medicale (Paris, France : 1983), 2005, Jan-15, Volume: 34, Issue:1

    Topics: Aged; Anti-Inflammatory Agents; Antitubercular Agents; Confusion; Disease Progression; Drug Therapy,

2005
Clinical-epidemiological profile of children with schistosomal myeloradiculopathy attended at the Instituto Materno-Infantil de Pernambuco.
    Memorias do Instituto Oswaldo Cruz, 2006, Volume: 101 Suppl 1

    Topics: Adolescent; Anthelmintics; Child; Child, Preschool; Female; Humans; Male; Neuroschistosomiasis; Oxam

2006
[Mansonic neuroschistosomiasis: clinical, laboratory and therapeutic aspects].
    Arquivos de neuro-psiquiatria, 1996, Volume: 54, Issue:2

    Topics: Adolescent; Adult; Female; Humans; Male; Meningitis; Middle Aged; Myelitis; Praziquantel; Prednisone

1996
Bifocals and cervical radiculopathy: a clinical reminder.
    Muscle & nerve, 1999, Volume: 22, Issue:2

    Topics: Eyeglasses; Female; Humans; Male; Middle Aged; Neck Pain; Prednisone; Radiculopathy; Spinal Nerve Ro

1999
Tuberculous meningiomyeloradiculitis--a report of two cases.
    Tubercle, 1991, Volume: 72, Issue:1

    Topics: Adolescent; Adult; Female; Humans; Myelitis; Myelography; Prednisone; Radiculopathy; Tuberculosis, M

1991
[Principles and limits of ACTH-cortisone therapy in neurology].
    Bibliotheca psychiatrica et neurologica, 1969, Volume: 139

    Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Cortisone; Dexamethasone; Epilepsy; Facial Par

1969